Search

everythinglearnresearchcommunity

for

Search:↓

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Acute leukemias with the Philadelphia chromosome may be biphenotypic, and identifying this is important for proper treatment.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

Certain genetic variations in IL-16 may increase the risk of alopecia areata.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

The circadian clock is crucial for tissue renewal and regeneration, affecting stem cell functions and having implications for health and disease.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Activating β-catenin in different skin stem cells causes various types of hair growth and skin tumors.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

The document concludes that while there are promising methods to control CRISPR/Cas9 gene editing, more research is needed to overcome challenges related to safety and effectiveness for clinical use.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

miR-140-5p in certain cell vesicles helps hair growth by boosting cell proliferation.

A combination of oral cyclosporin and PUVA treatment worked well for a severe skin condition called generalized pustular psoriasis.

Follicular Cell Implantation might become a new treatment for hair loss and could lead to advances in organ regeneration.

Fetal-maternal stem cells in a mother's hair can help with tissue repair and regeneration long after childbirth.

The document suggests a need for collaboration, better evidence, and a responsible framework to safely and effectively advance regenerative therapies to clinical use.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

HO-1 helps skin health and healing but can worsen melanoma; it's a potential treatment target for skin diseases.

A woman's small, unnoticed adrenal mass turned out to be a rare non-Hodgkin's lymphoma, treated successfully with surgery and therapy.